These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16477462)

  • 1. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa.
    Knipping S; Holzhausen HJ; Goetze G; Riederer A; Bloching MB
    Otolaryngol Head Neck Surg; 2007 Jan; 136(1):57-61. PubMed ID: 17210334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B; Gotlib T; Samoliński B
    Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.
    Cam B; Sari M; Midi A; Gergin O
    Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3123-3130. PubMed ID: 31468129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rhinitis medicamentosa, an increasing problem. Do nose drops adversely affect bacterial infections?].
    Wilhelmson B
    Lakartidningen; 1994 Dec; 91(49):4635-6. PubMed ID: 7808178
    [No Abstract]   [Full Text] [Related]  

  • 11. Rhinitis medicamentosa as a cause of increased intraoperative bleeding.
    Robison JG; Pant H; Ferguson BJ
    Laryngoscope; 2010 Oct; 120(10):2106-7. PubMed ID: 20824778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal changes in rhinitis medicamentosa.
    Lin CY; Cheng PH; Fang SY
    Ann Otol Rhinol Laryngol; 2004 Feb; 113(2):147-51. PubMed ID: 14994772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhinitis medicamentosa: electron microscopic study.
    Talaat M; Belal A; Aziz T; Mandour M; Maher A
    J Laryngol Otol; 1981 Feb; 95(2):125-31. PubMed ID: 6161977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress on rhinitis medicamentosa].
    Wang YN; Luan ZL; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):872-875. PubMed ID: 29141305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):334-9. PubMed ID: 7530821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The observation of the ciliotoxicity of nasal mucosa with nasal decongestant].
    Teng Y; Zhang X; Xu G; Cai Q; Xu J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):824-6. PubMed ID: 16375111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].
    Yuta A; Ogawa Y
    Arerugi; 2013 Dec; 62(12):1623-30. PubMed ID: 24608651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.